about
Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation.Hexoneogenesis in the human breast during lactation.Contribution of plasma galactose and glucose to milk lactose synthesis during galactose ingestion.Regulation of lipolysis: natriuretic peptides and the development of cachexia.Determinants of vascular function in patients with type 2 diabetes.Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves' orbitopathy and analysis on who requires additional therapy.The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia.The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.Prolactin levels in drug-naïve patients with schizophrenia and other psychotic disorders.Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.Endocrine and metabolic manifestations in inflammatory bowel diseaseRelapsing Episodes of Loss of Consciousness in a Patient With Hepatocellular Carcinoma.Metabolic adaptation to feeding and fasting during lactation in humans.Impact of duration of infusion and choice of isotope label on isotope recycling in glucose homeostasis.Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?Association of vascular indices with novel circulating biomarkers as prognostic factors for cardiovascular complications in patients with type 2 diabetes mellitus.A 42 year old man with bilateral exophthalmos and weight loss.Recovery from reproductive impact of androgen abuse.Association of the (TAAAA)n repeat polymorphism of SHBG gene with the age at menopause in Greek postmenopausal women.Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women.Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia.Parameters of glucose and lipid metabolism at the fasted state in drug-naïve first-episode patients with psychosis: Evidence for insulin resistance.Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.Cushing's Syndrome Due to CRH and ACTH Co-secreting Pancreatic Tumor--Presentation of a New Case Focusing on Diagnostic Pitfalls.Adrenal reserve following treatment of Graves' orbitopathy with intravenous glucocorticoids.Severe resistant hypoglycemia in a patient with a pancreatic neuroendocrine tumor on sunitinib treatment.Simultaneous Cushing's disease and tuberous sclerosis; a potential role for TSC in pituitary ontogenyHypokalemic paralysis following administration of intravenous methylprednisolone in a patient with Graves' thyrotoxicosis and ophthalmopathyImpact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysisChanging prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitorsProprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor use in the management of resistant hypercholesterolemia induced by mitotane treatment for adrenocortical cancerChoroidal metastasis from papillary thyroid cancer: An unusual feature of a common diseaseSerum vitamin D in obese and overweight subjects according to estimated glomerular filtration rateClinical pharmacology of glucagon-like peptide-1 receptor agonistsTCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndromeA modified flow cytometry method for objective estimation of human CD4+ regulatory T cells (CD4+ Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labelingCanagliflozin and Amputation Risk: Evidence So FarRe: Clover et al. Transformation of a non-secretory neuro-endocrine tumor to insulinoma after treatment with Sunitinib: a case report and review of the literature. J Oncol Pharm Pract 2018. DOI: 10.1177/1078155218791309: Sunitinib-associated hyperinMetabolically Healthy Obesity Is Characterized by a Proinflammatory Phenotype of Circulating Monocyte Subsets
P50
Q30235442-22519008-709C-4FB5-863E-722D19A8D570Q33787727-787C9ECE-D223-41EE-9ED0-9E0C59ABAEEFQ34109173-4F2D724D-FBE0-40AF-96E7-C897D8559EA0Q34169428-4D35ECDB-5EA7-4C04-B656-872694EBF884Q34774452-85D606B0-6A09-4FC0-BC95-BCEBDF016344Q36376525-A68F6412-6FCD-46C6-A834-ED04F9069D51Q37426835-00936CDA-3F41-4197-BE4E-B775FD3B1387Q38350443-D698599B-6989-4168-8820-993A1F3B1DEFQ38862772-0C5F1699-E8A5-496A-A2A1-F1E307C74206Q40686668-A418695B-FD0E-4B5F-960C-1600D79798B2Q41686216-788799D1-3B5D-4957-8A7D-AAEEA7342575Q42406756-BD2D738F-A8B4-480C-9744-F26549C38EAAQ43606966-834DBAD3-333A-4FEF-B898-84E0A2B175E2Q43852994-DA2605CF-0DD5-4811-BCAE-1FE1E76A8530Q44195258-B02706E2-96A6-4CA6-9554-69AC22193A65Q47219119-7BFEA970-AA45-4644-A8AC-E7FDD6AD546CQ47243554-FBB8F04C-4091-428C-9692-B443BAE85B86Q47384748-EA9C59DF-0E7D-4606-A9D8-DA6D0BD123CEQ47547428-83C266D7-B6D5-4007-91C6-50C7C52801F4Q51143481-6D51C950-F932-4915-94CB-5ABC17573A59Q51154398-6CEFA413-005C-4A46-BBCC-1993151AEFDAQ51238908-FAA03C5D-26BD-42A9-BE2E-04BB57ADB9CFQ51298492-3CF4D499-458D-49F1-8CFB-E0572358B0BEQ51426269-1C09BCBE-AAE1-4CD0-93DD-A6035EB60B6AQ53412905-20B8C124-906A-4EC1-B5D1-4BD591972F4FQ53634232-B4423941-1D17-42CD-B3D8-36C93E02E19BQ54299105-64C70E21-13F8-4A83-9766-260FCD620268Q81604826-078002BE-A8D6-43B7-8D54-4B319986AD3AQ83335036-854EC789-9AC8-400A-BE5E-53433C10EAF1Q85478371-E5FCD8B2-4D75-48E9-B69D-52732F0C1294Q88144006-FBCF4F51-4172-43F0-BF02-4E5BBFECF827Q88344929-AC5F24D6-485B-4BCB-AAF6-BBA79AD47474Q88843341-938B78C0-0AE7-4145-91C7-6D7559F2E123Q88956513-B2A03E06-7E28-4289-B86C-ADABB4FA3DA6Q89289030-F865425A-B08D-43C1-AE59-A1D8050686E2Q89414779-D549FA49-49EA-4904-A391-CB6094534C9AQ90394557-380867B0-60D2-487F-A4B9-63673714DF9AQ91169399-D60ED00F-D9C6-4271-B299-51CF35AE2B6BQ91553905-4D403C0F-C38A-4E42-B041-8BC3EEE6CB09Q92324032-0FDCF0CB-024B-48CC-BAE5-DD150076E354
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stelios Tigas
@ast
Stelios Tigas
@en
Stelios Tigas
@es
Stelios Tigas
@nl
Stelios Tigas
@sl
type
label
Stelios Tigas
@ast
Stelios Tigas
@en
Stelios Tigas
@es
Stelios Tigas
@nl
Stelios Tigas
@sl
prefLabel
Stelios Tigas
@ast
Stelios Tigas
@en
Stelios Tigas
@es
Stelios Tigas
@nl
Stelios Tigas
@sl
P106
P1153
6506586230
P21
P31
P496
0000-0001-7325-8983